Oramed Pharmaceuticals Inc. Company Profile
NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Oramed Pharmaceuticals at a glance
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY, Israel. Oramed Pharmaceuticals is led by Mr. Nadav Kidron Esq.. At a market capitalization of $174.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001176309, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Oramed Pharmaceuticals do?
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Oramed Pharmaceuticals Inc.
- Ticker
- NASDAQ: ORMP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Nadav Kidron Esq.
- Headquarters
- 1185 Avenue of the Americas, New York, NY, Israel
- Phone
- 844 967 2633
- Website
- oramed.com
- Market cap
- $174.71M
- SEC CIK
- 0001176309
Companies similar to Oramed Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANTXAN2 Therapeutics Inc. | 4.68 | -3.51% | $176.61M | vs ORMP |
| DERMJourney Medical Corporation | 5.95 | 0.00% | $167.94M | vs ORMP |
| ORGOOrganogenesis Holdings Inc. Class A | 1.28 | -3.03% | $164.70M | vs ORMP |
| PEPGPepGen Inc. | 2.38 | -0.83% | $164.62M | vs ORMP |
| YARWYarrow Bioscience Inc. | 19.87 | +5.83% | $184.88M | vs ORMP |
| ALXOALX Oncology Holdings Inc. | 1.18 | +4.42% | $163.17M | vs ORMP |
| CUECue Biopharma Inc. | 22.33 | -0.80% | $162.21M | vs ORMP |
| EMISEmmis Acquisition Corp. Class A | 10.27 | 0.00% | $162.02M | vs ORMP |